TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue British Journal of Biomedical Science Année : 2019

TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection

, , , , (1) , ,
1
I Sghaier
  • Fonction : Auteur
S. Zidi
  • Fonction : Auteur
L. Mouelhi
  • Fonction : Auteur
E. Ghazoueni
  • Fonction : Auteur
W. Y. Almawi
  • Fonction : Auteur
B. Y. Loueslati
  • Fonction : Auteur

Résumé

Background: Chronic infection with hepatitis B (HBV) and C virus (HCV) is linked with a pro-inflammatory state, predisposing to cirrhosis and liver cancer, particularly hepatocellular carcinoma (HCC). A role for Toll-like receptor (TLR) signalling in hepatocarcinogenesis was recently documented. We hypothesised a link TLR3 and TLR4 polymorphisms and HCC, as surrogates for the significance of TLR signalling in the promotion and initiation of HCC. Materials and methods: We recruited 174 HCV-infected patients, 100 HBV-infected patients and 360 healthy control subjects. TLR3 (rs3775290) and TLR4 (rs4986790) genotyping was done by PCR-restriction fragment length polymorphisms (PCR-RFLP), LFTs and AFP by standard routine techniques. Liver fibrosis was assessed clinically by the Fibrotest and Actitest. Result: The TLR3 rs3775290 minor T genotype was linked with increased risk of chronic HBV (P = 0.05) and HCV (P = 0.031) infection. The TLR4 rs4986790 minor G genotype was linked with significantly increased risk for HBV/HCV chronic infection (P < 0.001). Subgroups analyses indicated decreased risk of HBV-related HCC in relation to TLR3 rs3775290 CC/CT genotype (P = 0.022), with increased risk ascribed to the minor (T) allele (P = 0.04). Likewise, TLR4 rs4985790 minor (GG) genotype was positively associated with HBV-linked HCC (P < 0.001). Furthermore, a link between TLR3 TT (P < 0.001) andTLR4 GG (P = 0.04) minor genotypes was noted in relation to increased risk of HCV-related disease. Conclusion: TLR3 and TLR4 polymorphisms are promising biomarkers of liver cirrhosis and cancer associated with HBV and HCV infection.
Fichier non déposé

Dates et versions

hal-03591573 , version 1 (28-02-2022)

Identifiants

Citer

I Sghaier, S. Zidi, L. Mouelhi, E. Ghazoueni, Etienne Brochot, et al.. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection. British Journal of Biomedical Science, 2019, 76 (1), pp.35-41. ⟨10.1080/09674845.2018.1547179⟩. ⟨hal-03591573⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More